Why Is Jaguar Health (JAGX) Stock Down 55% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Jaguar Health stock is down on Tuesday as JAGX investors react to failed results from a Phase 3 clinical trial of crofelemer.
The post Why Is Jaguar Health (JAGX) Stock Down 55% Today? appeared first on InvestorPlace.
More From InvestorPlace